Consolidated Statements of Changes In Shareholders' Equity - USD ($) $ in Thousands		Total	Cumulative Effect, Period of Adoption, Adjustment	[2]	Common Stock	Additional Paid-in Capital	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	[2]	Accumulated Other Comprehensive (Loss) Income	Treasury Stock
Beginning balance (in shares) at Dec. 31, 2021					16,056,282
Beginning balance at Dec. 31, 2021		$ 490,076			$ 16,056	$ 384,742	$ 91,043			$ 158	$ (1,923)
Net income		54,806					54,806
Total other comprehensive loss, net of taxes		(19,374)								(19,374)
Common stock cash dividends declared - $0.80 per share		(12,735)					(12,735)
Common stock issued to shareholders in acquisition	[1]	776				776
Repurchased stock		(2,957)									(2,957)
Employee Stock Purchase Plan (in shares)					7,152
Employee Stock Purchase Plan		200			$ 7	193
Director Stock Purchase Plan (in shares)					5,876
Director Stock Purchase Plan		165			$ 6	159
Restricted stock activity (in shares)					25,176
Restricted stock activity		1,142			$ 25	1,117
Ending balance (in shares) at Dec. 31, 2022					16,094,486
Ending balance at Dec. 31, 2022		512,099	$ (11,548)		$ 16,094	386,987	133,114	$ (11,548)		(19,216)	(4,880)
Net income		37,397					37,397
Total other comprehensive loss, net of taxes		2,579								2,579
Common stock cash dividends declared - $0.80 per share		(12,981)					(12,981)
Common stock issued to shareholders in acquisition (in shares)	[3]				849,510
Common stock issued to shareholders in acquisition	[3]	18,095			$ 850	17,245
Repurchased stock	[4]	(4,876)				(37)					(4,839)
Employee Stock Purchase Plan (in shares)					13,459
Employee Stock Purchase Plan		303			$ 13	290
Director Stock Purchase Plan (in shares)					7,884
Director Stock Purchase Plan		179			$ 8	171
Restricted stock activity (in shares)					33,590
Restricted stock activity		$ 1,103			$ 34	1,069
Ending balance (in shares) at Dec. 31, 2023		16,573,707			16,998,929
Ending balance at Dec. 31, 2023		$ 542,350			$ 16,999	405,725	145,982			(16,637)	(9,719)
Net income		49,437					49,437
Total other comprehensive loss, net of taxes		(188)								(188)
Common stock cash dividends declared - $0.80 per share		(13,822)					(13,822)
Common stock issued to shareholders in acquisition (in shares)	[5]				2,731,250
Common stock issued to shareholders in acquisition	[5]	75,956			$ 2,731	73,225
Repurchased stock	[4]	(323)									(323)
Employee Stock Purchase Plan (in shares)					19,829
Employee Stock Purchase Plan		438			$ 20	418
Director Stock Purchase Plan (in shares)					5,072
Director Stock Purchase Plan		123			$ 5	118
Restricted stock activity (in shares)					41,439
Restricted stock activity		$ 1,047			$ 42	1,005
Ending balance (in shares) at Dec. 31, 2024		19,355,797			19,796,519
Ending balance at Dec. 31, 2024		$ 655,018			$ 19,797	$ 480,491	$ 181,597			$ (16,825)	$ (10,042)

[1] Additionally, 2,500 shares of restricted stock were paid out in cash resulting in $776 thousand of cash consideration relating to stock awards.

[2] The Corporation adopted ASC 326, Financial Instruments - Credit Losses, effective January 1, 2023. See "Note 1 - Summary of Significant Accounting Policies" for further details.

[3] Shares issued as a result of the acquisition of Brunswick Bancorp ("Brunswick"). See "Note 2 - Business Combinations", to the Consolidated Financial Statements for more information.

[4] Includes tax effects of repurchased stock.

[5] Shares issued as a result of the underwritten public offering of 2,375,000 shares of common stock at a price of $29.50 per share on November 4, 2024.